首页> 中文期刊> 《中国中医急症 》 >痰热清注射液治疗重型颅脑损伤患者气管切开并发肺部感染临床观察∗

痰热清注射液治疗重型颅脑损伤患者气管切开并发肺部感染临床观察∗

             

摘要

Objective:To observe the clinical curative effect of Tanreqing Injection on pulmonary infection af⁃ter tracheostomy in patients with severe traumatic brain injury. Methods:80 cases of severe traumatic brain in⁃jury after tracheotomy in patients with pulmonary infection were randomly divided into treatment group and con⁃trol group with 40 cases in each group. The control group were treated with conventional treatment;treatment group were given Tanreqing injection on the basis of control group. Symptoms and signs,markers of inflammation were compared between the two groups after treatment to restore the normal time and curative effect. Results:The total effective rate of treatment group was higher than that of the control group,the observation index recov⁃ery time was shorter than the control group(P<0.05). Conclusion:Clinical efficacy of Tanreqing Injection in the treatment of pulmonary infection after tracheostomy in patients with severe traumatic brain injury is signifi⁃cant,the compliance of patients is good,whidh is worth the clinical promotion.%目的:观察痰热清注射液治疗重型颅脑损伤患者气管切开后并发肺部感染的临床疗效。方法将80例重型颅脑损伤气管切开后并发肺部感染患者随机分为治疗组和对照组,各40例,对照组采用常规治疗,治疗组在对照组基础上加用痰热清注射液静脉滴注。比较两组患者治疗后临床疗效及症状体征、炎症指标恢复正常时间。结果治疗组总有效率97.50%,高于对照组之77.50%(P<0.05);治疗组症状体征、炎症指标恢复正常时间明显短于对照组(P<0.05)。结论痰热清注射液治疗重型颅脑损伤患者气管切开后并发肺部感染的临床疗效显著,患者依从性好。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号